Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
20%
Ph phase_1
1
20%
Ph phase_3
1
20%

Phase Distribution

1

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 2Efficacy & side effects
1(33.3%)
Phase 3Large-scale testing
1(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(3)
Other(2)

Detailed Status

Completed3
unknown2

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (33.3%)
Phase 21 (33.3%)
Phase 31 (33.3%)

Trials by Status

unknown240%
completed360%

Recent Activity

0 active trials
Showing 5 of 5
completed

Combined CRS With HIPEC in Women With Inadvertently Morcellated uLMS

NCT06678763
completedphase_1

A Phase Ib/II Study of Efficacy and Feasibility of Cytoreductive Surgery, Extensive Peritoneal Lavage, Hyperthermicintraperitoneal Chemotherapy and Post-operative Intraperitoneal Chemotherapy Combination in Gastric Cancer With Peritoneal Metastasis

NCT02995850
unknownphase_2

Preoperative Systemic Therapy for Colorectal Cancer Peritoneal Metastases

NCT05353582
unknownphase_3

A Randomized Prospective Trail of HIPEC in Recurrent Ovarian Cancer Patients With HRR Mutation

NCT04473339
completed

Thrombin Generation and Platelet Activation in CRS/HIPEC

NCT03034850

Clinical Trials (5)

Showing 5 of 5 trials
NCT06678763

Combined CRS With HIPEC in Women With Inadvertently Morcellated uLMS

Completed
NCT02995850Phase 1

A Phase Ib/II Study of Efficacy and Feasibility of Cytoreductive Surgery, Extensive Peritoneal Lavage, Hyperthermicintraperitoneal Chemotherapy and Post-operative Intraperitoneal Chemotherapy Combination in Gastric Cancer With Peritoneal Metastasis

Completed
NCT05353582Phase 2

Preoperative Systemic Therapy for Colorectal Cancer Peritoneal Metastases

Unknown
NCT04473339Phase 3

A Randomized Prospective Trail of HIPEC in Recurrent Ovarian Cancer Patients With HRR Mutation

Unknown
NCT03034850

Thrombin Generation and Platelet Activation in CRS/HIPEC

Completed

All 5 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
5